Novo Nordisk: shareholders approve new board member
(CercleFinance.com) - Shareholders of Denmark's Novo Nordisk, the world's biggest maker of diabetes drugs, on Thursday approved a new member for the company's board of directors, along with a share buyback plan.
The shareholders approved Laurence Debroux, Heineken's CFO, to serve as new board member at the annual general meeting.
Helge Lund's re-election as board chairman was also approved, as well as the group's final dividend for 2018.
The shareholders also allowed the company to repurchase own shares, representing up to 10% of its total share capital.
A proposal from a shareholder to reduce prices if the return on equity exceeded 7%, was not adopted, however.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The shareholders approved Laurence Debroux, Heineken's CFO, to serve as new board member at the annual general meeting.
Helge Lund's re-election as board chairman was also approved, as well as the group's final dividend for 2018.
The shareholders also allowed the company to repurchase own shares, representing up to 10% of its total share capital.
A proposal from a shareholder to reduce prices if the return on equity exceeded 7%, was not adopted, however.
Copyright (c) 2019 CercleFinance.com. All rights reserved.